Quarterly report pursuant to Section 13 or 15(d)

SEGMENT INFORMATION (Details)

v3.8.0.1
SEGMENT INFORMATION (Details) - USD ($)
3 Months Ended 9 Months Ended
Sep. 30, 2017
Sep. 30, 2016
Sep. 30, 2017
Sep. 30, 2016
Dec. 31, 2016
Revenues $ 317,450 $ 326,667 $ 758,487 $ 326,667  
Depreciation 24,322   58,478  
Interest expenses 52,932   94,932    
Net income (loss) before provision for income taxes (710,729) 207,874 (1,690,570) 102,403  
Identifiable long-lived tangible assets 7,701,927   7,701,927   $ 295
Medical related consulting services [Member]          
Revenues 2,166 326,667 220,949 326,667  
Depreciation 3,754   4,967    
Net income (loss) before provision for income taxes (116,230) $ 207,874 (278,019) $ 102,403  
Identifiable long-lived tangible assets 23,932   23,932   $ 295
Real property operating [Member]          
Revenues 315,284   537,538    
Depreciation 20,568   53,511    
Interest expenses 52,932   94,932    
Net income (loss) before provision for income taxes (119,782)   (121,016)    
Identifiable long-lived tangible assets 7,677,995   7,677,995    
Others [Member]          
Net income (loss) before provision for income taxes [1] $ (474,717)   $ (1,291,535)    
[1] The Company does not allocate any general and administrative expense of its being a public company activities to its reportable segments as these activities are managed at a corporate level.